Phibro Animal Health Co. (PAHC) To Go Ex-Dividend on March 5th

Phibro Animal Health Co. (NASDAQ:PAHC) declared a quarterly dividend on Tuesday, February 4th, RTT News reports. Investors of record on Wednesday, March 5th will be paid a dividend of 0.12 per share on Wednesday, March 26th. This represents a $0.48 dividend on an annualized basis and a yield of 2.11%. The ex-dividend date is Wednesday, March 5th.

Phibro Animal Health has a dividend payout ratio of 24.7% meaning its dividend is sufficiently covered by earnings. Analysts expect Phibro Animal Health to earn $2.10 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 22.9%.

Phibro Animal Health Stock Up 2.8 %

PAHC stock opened at $22.74 on Monday. The company has a market cap of $921.04 million, a price-to-earnings ratio of 47.38, a PEG ratio of 0.45 and a beta of 0.52. The firm has a 50-day moving average of $22.24 and a two-hundred day moving average of $22.34. Phibro Animal Health has a 12 month low of $11.98 and a 12 month high of $26.55. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. As a group, analysts forecast that Phibro Animal Health will post 1.95 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

PAHC has been the subject of a number of research reports. Morgan Stanley lifted their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. StockNews.com lowered Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 6th. Finally, Barclays boosted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research note on Monday, February 10th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, Phibro Animal Health presently has an average rating of “Hold” and a consensus price target of $21.00.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.